There’s been talk about liquid biopsies and the promise of using blood samples to test for a wide variety of cancers at once.

NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.

(Alliance News) - Cizzle Biotechnology Holdings PLC on Monday saw its shares surge as it reported that the process of preparing for submission of its CIZ1B test for Clinical Laboratory Improvement ...

You can get at-home medical tests for everything from Covid-19 to drug testing to hormone levels or food sensitivities. You can examine your gut, your blood, or even your DNA. At-home STI tests use ...

Drug test cups remain a frontline tool for employers, clinics, and occupational health providers who need fast, reliable urine screening ...

Wholly-owned laboratory has received CLIA certification from Massachusetts with full license to conduct patient testing and ...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...

Reducing Uncertainty in the Care and Treatment of Blood Cancer ST. LOUIS, MO, UNITED STATES, February 23, 2026 ...

Cizzle Biotechnology of York is set for a multi-million dollar boost as it moves towards launching a product to detect lung cancer at an early stage.

Researchers have known for decades that different brands of lab machines produce different results. The fix is easy — but not ...

Irvine-based biotech startup NeuroQure has launched ASD Insight, the first-of-its-kind biological test to identify autism risk as early as birth.

HighER Level Urgent Care offers CBC testing enabled by CitoCBC®, a CLIA-waived blood analyzer designed for use in ...